Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta2-adrenergic agonist (salbutamol) in chronic renal failure patients

Journal of Korean Medical Science

Volumn 12, Issue 2, 1997, Pages 111-116

  Kim, Ho Jung ^a  

^a Hanyang University   (South Korea)

Author keywords

Bicarbonate; Hyperkalemia; Metabolic acidosis; Salbutamol; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; POTASSIUM; SALBUTAMOL;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; DRUG COMBINATION; FEMALE; HEART RATE; HUMAN; HYPERKALEMIA; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PH;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POTASSIUM; SODIUM BICARBONATE;

EID: 0031110969     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1997.12.2.111     Document Type: Article

References (17)

1. Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 1993 ; 43 : 1197-209.
2. Allon M. Hyperkalemia in end-stage renal disease : mechanisms and management. J Am Soc Nephrol 1995 ; 6 : 1134-41.
3. Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 1992 ; 41 : 369-74.
4. DeFronzo RA, Smith JD. Clinical disorders of hyperkalemia. In: Narins RG, ed. Clinical Disorders of Fluid and Electrolyte Metabolism, 5th ed. New York: McGraw-Hill, 1994 ; 697-754.
5. Iqbal Z, Friedman EA. Preferred therapy of hyperkalemia in renal insufficiency : Survey of nephrology training-program directors. N Engl J Med 1989 ; 320 : 60-1.
6. Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Int Med 1989 ; 110 : 426-9.
7. Liou HH, Chiang SS, Wu SC, Huang TP, Campese VM, Smogorzewski M, Yang WC. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure : Comparative study. Am J Kid Dis 1994 ; 23 : 266-71.
8. Blumberg A, Weidmann P, Shaw S, Gnadinger M. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988 ; 85 : 507-12.
9. Kim HJ. Combined effect of bicarboimte and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996 ; 72 : 476-82.
10. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990 ; 38 : 869-72.
11. Brynger H, Brunner FP, Chantier C, Donckerwolcke RA, Jacobs C, Kramer P, Selwood NH, Wing A. Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 1980 ; 17 : 4-86.
12. Siddiqui JY, Fitz AE, Lawton RL, Kirkendall WH. Causes of death in patients receiving long term hemodialysis. JAMA 1970 ; 212 : 1350-4.
13. Tzamaloukas AH, Avasthi PS. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. Am J Nephrol 1987 ; 7 : 101-9.
14. Barr G, DeFronzo RA. Treatment of hyperkalemia. In : Glassock RJ, ed. Current therapy in nephrology and hypertension, Vol 3. Philadelphia : Decker, 1991 ; 84-96.
15. Clausen T, Flatman J. The effect of catecholamines on Na-K transport and membrane potential in rat soleus muscle. J Physio (Lond) 1977 ; 270 : 383-414.
16. Deepak K, Kahn T. Na-K pump in chronic renal failure. Am J Physiol 1987 ; F785-F793.
17. Goguen JM, Halperin ML. Can insulin administration cause an acute metabolic acidosis in vivo? An experimental study in dogs. Diabetologia 1993 ; 36 : 813-6.